As counsel to several health care and business groups appearing as amici curiae, successfully handled significant products liability appeals, convincing the New Jersey Supreme Court that labels on the acne drug Accutane were adequate under New Jersey law, and that the state should adopt the Daubert factor-based approach for determining the admissibility of expert testimony. In the latter landmark case, which altered New Jersey law on expert testimony admissibility, the Supreme Court’s decision relied upon and cited McCarter’s argument. Also successfully briefed and argued in another appeal that New Jersey’s two-year statute of limitations should apply in products cases involving a prescription medicine.